Author
Gufic Biosciences launches India’s first indigenous botulinum toxin injection ‘Zarbot’
The injection has been manufactured using purified Hall strain and proprietary technology which results in thin film formulation…
Cipla and Ethris partner to develop mRNA-based therapies
A collaboration agreement is signed concurrently with the definitive agreement, which paves a path to market Ethris’s innovative…
Claims against Dr Reddy’s over Revlimid in US dismissed
On 22nd December, 2022 and 27th December, 2022, the plaintiffs voluntarily dismissed Dr Reddy’s Laboratories Limited and Dr…
CDSCO orders audits of pharmacovigilance system of importers and manufacturers of human vaccines
The CDSCO order also asked the importers and manufacturers to also furnish some of their documents to the directorate at the…
Japan approves AstraZeneca’s Calquence for adult patients with treatment-naïve CLL
Calquence was previously approved in Japan for the treatment of adults with relapsed or refractory Chronic Lymphocytic Leukaemia…
US FDA approves TG Therapeutics’ multiple sclerosis drug
The approval by the US Food and Drug Administration (USFDA) widens the number of such drugs available for treating the disorder to…
IPC launches 10 new IP impurities substances
The substances include Dolutegravir-4-fluoro-impurity, Ethyl Paraben, Fumaric Acid (Lamivudine and Tenofovir Tablets) and…
We plan to continue expanding our footprints in India, including producing quality excipients and…
Dr Vijay Ahire, Head, Pharma Business Unit at JRS Pharma, India, speaks on his company's growth trajectory, major milestones,…
Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2…
The disease generally has low mortality rate up to six per cent, but can increase significantly in the presence of other…